MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/apt.70797

Медицинская библиотека · Alimentary pharmacology & therapeutics · 2026

Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma.

Lim Ryan Yanzhe, Selvakumar Vigneshwaran, Syn Nicholas, Chen Gang, Li Jie, Kyaw Zin Myint, Zhou Juequn, Kim Beom Kyung, Wijarnpreecha Karn, Takahashi Hirokazu, Huang Daniel Q, Liver Cancer Research Network

СтатьяВалидационное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Prognostic models for hepatocellular carcinoma (HCC) may have limited accuracy. We aimed to construct and validate a novel prognostic model for HCC that incorporates biomarkers for liver function and tumour characteristics.

METHODS

Consecutive participants (n = 1102) with HCC from five international tertiary institutions in Asia and the U.S. comprised the derivation (n = 627), internal validation (n = 270) and external validation (n = 205) cohorts. The Liver Cancer Risk predictioN (LCRN) Index was constructed using a gradient-boosted decision tree model based on the Cox proportional hazards framework. The discriminative performance of the LCRN Index was evaluated using Harrell's concordance index (C-index) and compared to the albumin bilirubin grade (ALBI), Barcelona Clinic for Liver Cancer (BCLC) staging and Cox regression model. Model calibration was assessed using the integrated Brier score and calibration plots.

RESULTS

The median (IQR) age was 66.0 (58.0-73.0) years, median (IQR) body mass index was 23.9 (22.1-26.1) kg/m2 and 77.2% were male. The LCRN Index comprised type 2 diabetes mellitus, ascites, hepatic encephalopathy, albumin, bilirubin, AFP and diameter of largest tumour nodule. In the external validation cohort, the LCRN Index (1-year area under the receiver operating curve [AUC]: 0.79; 3-year AUC: 0.77; 5-year AUC: 0.75) was numerically higher than the ALBI grade and BCLC stage for prognosticating HCC. The LCRN Index demonstrated improved calibration compared to the ALBI grade and BCLC stage.

CONCLUSION

The LCRN index is a promising tool for prognosticating HCC. If further validated, these data may have potential clinical implications for the management of HCC.

Для цитирования: Lim Ryan Yanzhe, Selvakumar Vigneshwaran, Syn Nicholas, Chen Gang, Li Jie, Kyaw Zin Myint, Zhou Juequn, Kim Beom Kyung, Wijarnpreecha Karn, Takahashi Hirokazu, Huang Daniel Q, Liver Cancer Research Network. Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma.. Alimentary pharmacology & therapeutics. 2026. DOI: 10.1111/apt.70797.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.